Khiron Pharma Commerce ApS: Financial statements 2024
CVR: 37003204
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Khiron Pharma Commerce ApS (CVR 37003204) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 266,131 and a net result of DKK 4,240 compared with DKK 133,810 the year before. That is an increase of 72.8% compared with the year before. Equity in the 2024 report amounted to DKK 175,574. The solvency ratio was 24.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 266,131
- Profit/Loss
- DKK 4,240
- Equity
- DKK 175,574
- Total Assets
- DKK 719,620
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 266 t. | 4 t. | 176 t. | 1 |
| 2023 | - | 154 t. | 134 t. | 171 t. | 0 |
| 2022 | - | -61 t. | -62 t. | 38 t. | 0 |
| 2021 | - | 130 t. | 55 t. | 100 t. | 1 |
| 2020 | - | -33 t. | -69 t. | 45 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Khiron Pharma Commerce ApS has published its annual report for 2023. Gross profit came to DKK 154,052, and the net result was DKK 133,810.
About Khiron Pharma Commerce ApS
Khiron Pharma Commerce ApS is a Danish company of the type Anpartsselskab based in Frederiksværk, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Dan Henning Norden and Lone Lindquist-Nielsen. The company's owners include Lone Lindquist-Nielsen, Dan Henning Norden and Mette Rokkedal. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 780,426 and a net result of DKK 339,637 compared with DKK 4,240 the year before. Equity in the 2025 report amounted to DKK 515,211.